The relationship between the biomarker, and liver, bile duct or pancreas disease.

The relationship between the biomarker, and liver, bile duct or pancreas disease. - The relationship between the biomarker, and liver, bile duct or pancreas disease.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031568

Enrollment

200

Registered

2019-01-01

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the disease of liver, biliary, and pancreas

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)>20 years old 2)The patients obtained the consent 3)>4 weeks of suvival periods 4)AST and ALT > 6 times from the facilities standards

Exclusion criteria

Exclusion criteria: 1)The outcome evaluation is difficult for patient's condition 2)The execution plan of achievement is difficult

Design outcomes

Primary

Measure	Time frame
ADAMTS13 and VWF are biomarkers of HCC	—

Countries

Japan

Contacts

Public ContactHiroaki Takaya

Nara medical unversity 3rd department of interanal medicine

htky@naramed-u.ac.jp0744-22-3051

Outcome results